Personal information

Emails & domains

Verified email addresses

Other IDs

Scopus Author ID: 57783101200

Countries

Slovakia

Activities

Collapse all

Works (4)

Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease

United European Gastroenterology Journal
2025-04 | Journal article
DOI: 10.1002/ueg2.12633
Contributors: Tomas Koller; Petra Vrbova; Natalia Kubanek; Daniela Zilincanova; Svetlana Adamcova Selcanova; Daniel Jan Havaj; Lubomir Skladany
Source: check_circle
Crossref

3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation

EPMA Journal
2024-10-31 | Journal article
DOI: 10.1007/s13167-024-00381-5
Contributors: Lubomir Skladany; Natalia Kubanek; Svetlana Adamcova Selcanova; Daniela Zilincanova; Daniel Havaj; Karolina Sulejova; Katarina Soltys; Lucia Messingerova; Michal Lichvar; Lukas Laffers et al.
Source: check_circle
Crossref

Telemedicine in hepatology - promising solution for our patients?,Telemedicína v hepatológii - perspektívne riešenie pre našich pacientov?

Gastroenterologie a Hepatologie
2023 | Journal article
DOI: 10.48095/ccgh2023130
EID:

2-s2.0-85163748040

Part of ISSN: 1804803X 18047874
Contributors: Havaj, D.J.; Adamcová Selčanová, S.; Žilinčanová, D.; Vnenčáková, J.; Skladaný, Ľ.
Source: Self-asserted source
Daniel Ján Havaj via Scopus - Elsevier

Cirrhosis-associated immune dysfunction (CAID) – causes, phenotypes and consequences,S cirhózou asociovaná imunitná dysfunkcia (CAID) – príčiny, fenotypy a dôsledky

Gastroenterologie a Hepatologie
2022 | Journal article
DOI: 10.48095/ccgh2022101
EID:

2-s2.0-85133498301

Part of ISSN: 1804803X 18047874
Contributors: Havaj, D.J.; Skladaný, Ľ.
Source: Self-asserted source
Daniel Ján Havaj via Scopus - Elsevier
How many people are using ORCID?